🏛️ Verified NIH Record • Updated 2026-08-27
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis (NCT02808780)
Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Janssen Biotech, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to describe the long-term safety risks in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi.
Who can join: Review the eligibility criteria below.
Location: Clinical Research Facility — Murrieta, California
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (63 Sites)
Showing the first 25 of 63 sites.
- Clinical Research Facility — Murrieta, California
- Clinical Research Facility — Rialto, California
- Clinical Research Facility — Ventura, California
- Clinical Research Facility — Coral Gables, Florida
- Clinical Research Facility — Fort Myers, Florida
- Clinical Research Facility — Lake Worth, Florida
- Clinical Research Facility — Lauderdale Lakes, Florida
- Clinical Research Facility — Miami, Florida
- Clinical Research Facility — Tampa, Florida
- Clinical Research Facility — Suwanee, Georgia
- Clinical Research Facility — Chicago, Illinois
- Clinical Research Facility — Sylvania, Ohio
- Clinical Research Facility — Pittsburgh, Pennsylvania
- Clinical Research Facility — Houston, Texas
- Clinical Research Facility — San Antonio, Texas
- Clinical Research Facility — Lansdowne Town Center, Virginia
- Clinical Research Facility — Salzburg,
- Clinical Research Facility — Sankt Poelten Noe,
- Clinical Research Facility — Vienna,
- Clinical Research Facility — New Westminster, British Columbia
- Clinical Research Facility — Vancouver, British Columbia
- Clinical Research Facility — Oshawa, Ontario
- Clinical Research Facility — Ottawa, Ontario
- Clinical Research Facility — Pilsen,
- Clinical Research Facility — Clermont-Ferrand,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Ulcerative Colitis
- A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) — Dothan, Alabama
- Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis — San Diego, California
- A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants — Eden Prairie, Minnesota
- CP101 for the Treatment of Ulcerative Colitis — Boston, Massachusetts
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis — Los Angeles, California
- Angiographic Delivery of AD-MSC for Ulcerative Colitis — Rochester, Minnesota
Explore by condition: All Ulcerative Colitis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.